Scalper1 News
British big pharma AstraZeneca (AZN) turned down a second takeover bid from U.S. counterpart Pfizer (PFE) Friday, saying that the $106 billion offer was still too low. Pfizer’s stock dropped nearly 2%, while AstraZeneca’s held steady on the stock market today. As with Pfizer’s first bid, AstraZeneca’s board objected to the large proportion of stock in the $84.43-a-share offer. They also described Pfizer’s move as “tax-driven,” underscoring Wall Scalper1 News
Scalper1 News